Pfizer PFE
NYSE PFE
$29.57 +0.13 (+0.44%)
As of: Oct 16, 2026 · 3:59 PM EDT

Pfizer (PFE) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Pfizer's Liabilities and Shareholders Equity came in at $201.13 billion for Q2 2026, down 2.4% from $206.1 billion a year earlier and down 3.3% from the prior quarter.

Analysis

Pfizer (PFE) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Pfizer's Liabilities and Shareholders Equity was $208.16 billion, down 2.5% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $213.4 billion in FY2024 (-6.0%), $227 billion in FY2023 (+15.1%), $197.21 billion in FY2022 (+8.7%) and $181.48 billion in FY2021 (+17.7%).
  • The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q1 2023.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q4 2021 (growth of 17.7%), and the weakest in Q4 2024 (a decline of 6.0%).
  • Business Quant data shows PFE's Liabilities and Shareholders Equity at $208 billion (Q1 2026), $208.16 billion (Q4 2025) and $209 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 201.06 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 135.12 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 115.83 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 49.36 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 201.13 Bn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 27.42 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 201.13 Bn
Mar 29, 2026 208.00 Bn
Dec 31, 2025 208.16 Bn
Sep 28, 2025 209.00 Bn
Jun 29, 2025 206.10 Bn
Mar 30, 2025 208.03 Bn
Dec 31, 2024 213.40 Bn
Sep 29, 2024 219.48 Bn
Jun 30, 2024 216.19 Bn
Mar 31, 2024 221.10 Bn
Dec 31, 2023 227.00 Bn
Oct 1, 2023 215.02 Bn
Jul 2, 2023 220.17 Bn
Apr 2, 2023 196.00 Bn
Dec 31, 2022 197.21 Bn
Oct 2, 2022 195.35 Bn
Jul 3, 2022 195.29 Bn
Apr 3, 2022 184.00 Bn
Dec 31, 2021 181.48 Bn
Oct 3, 2021 179.19 Bn
API Access

Pfizer Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PFE&period=max&api_key=YOUR_API_KEY